Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729014 | SCV000856647 | pathogenic | not provided | 2017-09-18 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV000785957 | SCV000924539 | likely pathogenic | Congenital stationary night blindness 1C | 2018-06-15 | criteria provided, single submitter | research | The homozygous p.Arg916Ter variant was identified by our study in two siblings with congenital stationary night blindness. This variant has been identified in <0.01% (1/111676) of European (Non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Loss of function of the TRPM1 gene is an established disease mechanism in congenital stationary night blindness typ 1C, and this is a loss of function variant. In summary, although additional studies are required to fully establish its pathogenicity, this variant is likely pathogenic. |
Revvity Omics, |
RCV000785957 | SCV003810188 | likely pathogenic | Congenital stationary night blindness 1C | 2022-05-31 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001003230 | SCV001161309 | pathogenic | Congenital stationary night blindness | 2019-06-23 | no assertion criteria provided | research |